UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$204M |
| 2 |
WBA
Walgreens Boots Alliance
WBA
|
+$163M |
| 3 |
Visa
V
|
+$141M |
| 4 |
Alibaba
BABA
|
+$137M |
| 5 |
Freeport-McMoran
FCX
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
K
Kellanova
K
|
+$196M |
| 2 |
Infosys
INFY
|
+$163M |
| 3 |
Monster Beverage
MNST
|
+$144M |
| 4 |
Mastercard
MA
|
+$128M |
| 5 |
Procter & Gamble
PG
|
+$119M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 14.83% |
| 2 | Technology | 14.48% |
| 3 | Financials | 14.28% |
| 4 | Consumer Discretionary | 9% |
| 5 | Industrials | 8.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
901
Allegion
ALLE
$14.3B
| $7.41M | 0.01% |
155,617
+5,683
| +4% | +$298K |
|
|
MACK
902
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $7.37M | 0.01% |
106,687
+4,372
| +4% | +$234K |
|
|
PGH
903
DELISTED
Pengrowth Energy Corporation
PGH
| $7.34M | 0.01% |
1,397,630
+324,047
| +30% | +$2.02M |
|
904
Timken Company
TKR
$9.1B
| $7.31M | 0.01% |
172,345
-70,586
| -29% | -$3.25M |
|
905
FerroAtlántica
GSM
$775M
| $7.3M | 0.01% |
401,597
-29,632
| -7% | -$590K |
|
906
IQVIA
IQV
$38.9B
| $7.3M | 0.01% |
130,865
+30,364
| +30% | +$1.7M |
|
|
EVER
907
DELISTED
Everbank Financial Corp
EVER
| $7.28M | 0.01% |
412,255
-13,759
| -3% | -$261K |
|
|
SVC
908
Service Properties Trust
SVC
$1.02B
| $7.24M | 0.01% |
54,309
-845
| -2% | -$122K |
|
|
ANN
909
DELISTED
ANN INC
ANN
| $7.22M | 0.01% |
175,598
-12,281
| -7% | -$485K |
|
910
Pacira BioSciences
PCRX
$991M
| $7.18M | 0.01% |
74,099
-700
| -0.9% | -$68.1K |
|
911
iShares 20+ Year Treasury Bond ETF
TLT
$41.8B
| – | – |
0
| – | – |
|
912
Pediatrix Medical
MD
$2.11B
| $7.13M | 0.01% |
130,117
-3,676
| -3% | -$209K |
|
|
BLOX
913
DELISTED
Infoblox Inc
BLOX
| $7.12M | 0.01% |
482,668
-33,271
| -6% | -$432K |
|
914
KBR
KBR
$4.58B
| $7.11M | 0.01% |
377,539
+6,679
| +2% | +$145K |
|
|
OREX
915
DELISTED
Orexigen Therapeutics, Inc.
OREX
| $7.08M | 0.01% |
166,105
-16,050
| -9% | -$862K |
|
916
Reinsurance Group of America
RGA
$15.5B
| $7.07M | 0.01% |
88,258
+5,585
| +7% | +$455K |
|
917
Tanger
SKT
$4.66B
| $7.04M | 0.01% |
215,236
-296,800
| -58% | -$10.3M |
|
918
Suncor Energy
SU
$74.2B
| $7.04M | 0.01% |
194,660
+65,132
| +50% | +$2.61M |
|
|
MTEM
919
DELISTED
Molecular Templates, Inc.
MTEM
| $7.03M | 0.01% |
11,798
+517
| +5% | +$358K |
|
920
Mitsubishi UFJ Financial
MUFG
$253B
| $7.02M | 0.01% |
1,250,876
-117,934
| -9% | -$689K |
|
|
BEE
921
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
| $6.99M | 0.01% |
599,680
+70,700
| +13% | +$833K |
|
922
Revvity
RVTY
$12.8B
| $6.96M | 0.01% |
159,545
+7,785
| +5% | +$354K |
|
|
RYL
923
DELISTED
RYLAND GROUP INC
RYL
| $6.92M | 0.01% |
208,180
-15,363
| -7% | -$558K |
|
|
THOR
924
DELISTED
THORATEC CORPORATION
THOR
| $6.87M | 0.01% |
256,832
+115,023
| +81% | +$3.27M |
|
925
iShares Core S&P Mid-Cap ETF
IJH
$125B
| $6.84M | 0.01% |
250,020
-215
| -0.1% | -$6.06K |
|
Similar funds
UBS AM's Q3 2014 Portfolio in Review
As of Q3 2014, UBS AM held 2,623 positions worth $101B, up 1.8% from $99B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS AM's Q3 2014 filing shows 68 new, 1,056 increased, 515 reduced and 65 closed positions. Its largest new stake was Alibaba: 1,521,250 shares worth $135M. The largest sale was Kellanova, an estimated $196M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Technology and Financials.
- UBS AM's largest Q3 2014 buy was Alibaba: 1,521,250 shares worth $135M.
- UBS AM added most to Apple in Q3 2014, an estimated $204M increase.
- UBS AM's biggest Q3 2014 reduction was Kellanova, cutting an estimated $196M.
- UBS AM fully exited FOREST LABORATORIES INC in Q3 2014, selling an estimated $80.9M.
- UBS AM's ten largest holdings make up 15% of its $101B portfolio in Q3 2014.
- UBS AM opened 68 new positions and closed 65 in Q3 2014.
- UBS AM's portfolio value rose 1.8% quarter-over-quarter to $101B.
Based on UBS AM's 13F filing for Q3 2014, filed 28 Oct 2014.